Unknown

Dataset Information

Association of Novel Androgen Receptor Axis-Targeted Therapies With Diarrhea in Patients With Prostate Cancer: A Bayesian Network Analysis.


ABSTRACT:

Objective

To perform a systematic review and network meta-analysis to characterize the effect of novel androgen receptor axis-target (ARAT) agents on diarrhea and constipation.

Methods

We searched the Pubmed, Web of Science, and ClinicalTrials.gov up to September 2021 for phase 3 randomized controlled trials (RCTs) of patients receiving novel ARAT agents for prostate cancer (CaP). A Cochrane risk-of-bias tool was used to assess trial quality. The primary outcomes were risk ratio (RR) of any-grade diarrhea and constipation for patients receiving ARAT treatment. RRs of competing treatments were evaluated by pairwise and Bayesian network meta-analysis.

Results

In this study, 13 trials with 15,117 participants comparing 5 treatments (abiraterone, enzalutamid

SUBMITTER: Xiong X 

PROVIDER: S-EPMC8818787 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature